Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 25,706 | 13,008 | 113,721 | 16,924 | 10,412 |
| Gross Profit | 25,706 | 13,008 | 113,721 | 16,924 | 10,412 |
| Operating Expenses | 74,391 | 69,599 | 70,569 | 60,938 | 56,591 |
| Operating Income | -48,685 | -56,591 | 43,152 | -44,014 | -46,179 |
| Other Income | 675 | -1,622 | 3,720 | -3,431 | 7,806 |
| Pre-tax Income | -48,010 | -58,213 | 46,872 | -47,445 | -38,373 |
| Income Tax | 8 | N/A | 15,807 | 1,839 | 151 |
| Net Income Continuous | -48,018 | -58,213 | 31,065 | -49,284 | -38,524 |
| Net Income | $-48,018 | $-58,213 | $31,065 | $-49,284 | $-38,524 |
| EPS Basic Total Ops | -5.90 | -9.50 | 5.20 | -8.10 | -6.40 |
| EPS Basic Continuous Ops | -5.91 | -9.47 | 5.29 | -8.13 | -6.38 |
| EPS Diluted Total Ops | -5.90 | -9.50 | 5.20 | -8.10 | -6.40 |
| EPS Diluted Continuous Ops | -5.91 | -9.47 | 5.29 | -8.13 | -6.38 |
| EPS Diluted Before Non-Recurring Items | -5.90 | -9.50 | 4.20 | N/A | N/A |
| EBITDA(a) | $-49,722 | $-57,486 | $41,830 | $-44,669 | $-46,290 |